Is AZN or ELV cheaper?

On trailing earnings, ELV is cheaper: AZN trades at a 26.92 P/E and ELV at 17.19.

Which has grown faster, AZN or ELV?

Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus ELV at 9.97%.

Does AZN or ELV pay a bigger dividend?

AZN yields 1.79% and ELV yields 1.70% based on trailing dividends and the latest price.

Is AZN or ELV more profitable?

AZN runs the higher net margin — AZN at 17.19% versus ELV at 2.62%.

Which has been the better investment, AZN or ELV?

Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus ELV at 13.43%. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs Elevance Health Inc. (ELV)

AZN leads on 11 of 17 compared metrics, though ELV is the cheaper stock.

A side-by-side comparison of AstraZeneca PLC and Elevance Health Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — AZN vs ELV

growth of $100 · last 25y

AZN +299.9%ELV +1875.9%ELV compounded faster

AZN ELV

AZN vs ELV: by the numbers

•AZN is the larger company ($277.22B vs $87.75B market cap).
•ELV trades at the lower earnings multiple (17.19 vs 26.92 P/E).
•AZN converts more revenue to profit (17.19% vs 2.62% net margin).
•AZN grew revenue faster over the past five years (16.99% vs 9.97% CAGR).
•AZN pays the higher dividend yield (1.79% vs 1.70%).

Which is better, AZN or ELV?

Metric tally: AZN 11 · ELV 6

It depends on what you're optimizing for:

ValueELV(lower P/E)

GrowthAZN(faster 5Y revenue CAGR)

IncomeAZN(higher dividend yield)

QualityAZN(higher ROIC)

Valuation

Metric	AZN	ELV
P/E ratio	26.92	17.19●
Forward P/E	15.33	13.82●
P/S ratio	4.62	0.44●
P/B ratio	5.90	2.03●
PEG ratio	0.14●	2.58
EV / EBITDA	14.92	12.48●
FCF yield	3.26%	7.24%●

Profitability

Metric	AZN	ELV
Gross margin	81.68%●	23.16%
Operating margin	23.69%●	3.81%
Net margin	17.19%●	2.62%
ROE	21.95%●	11.94%
ROIC	13.03%●	6.65%

Dividends

Metric	AZN	ELV
Dividend yield	1.79%●	1.70%
Payout ratio	48.48%	27.24%

Growth (annualized)

Metric	AZN	ELV
Revenue CAGR (5Y)	16.99%●	9.97%
EPS CAGR (5Y)	22.02%●	6.67%
FCF CAGR (5Y)	18.52%●	-7.76%
Total return CAGR (5Y)	11.03%●	2.50%

Frequently asked

Which is better, AZN or ELV?: It depends on your goal. value: ELV (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 11 to 6.
Is AZN or ELV cheaper?: On trailing earnings, ELV is cheaper: AZN trades at a 26.92 P/E and ELV at 17.19.
Which has grown faster, AZN or ELV?: Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus ELV at 9.97%.
Does AZN or ELV pay a bigger dividend?: AZN yields 1.79% and ELV yields 1.70% based on trailing dividends and the latest price.
Is AZN or ELV more profitable?: AZN runs the higher net margin — AZN at 17.19% versus ELV at 2.62%.
Which has been the better investment, AZN or ELV?: Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus ELV at 13.43%. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full ELV analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio Elevance Health P/E ratio AstraZeneca dividend yield Elevance Health dividend yield AstraZeneca ROE Elevance Health ROE AstraZeneca operating margin Elevance Health operating margin AstraZeneca revenue growth Elevance Health revenue growth AstraZeneca free cash flow Elevance Health free cash flow

AstraZeneca & Elevance Health appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks Largest Companies by Market Cap

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.